- Home
- SIBN vs GAIN Comparison
SIBN vs GAIN Comparison
Compare SIBN & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIBN
- GAIN
- Stock Information
- Founded
- SIBN 2008
- GAIN 2005
- Country
- SIBN United States
- GAIN United States
- Employees
- SIBN N/A
- GAIN N/A
- Industry
- SIBN Medical/Dental Instruments
- GAIN Finance: Consumer Services
- Sector
- SIBN Health Care
- GAIN Finance
- Exchange
- SIBN Nasdaq
- GAIN Nasdaq
- Market Cap
- SIBN 571.0M
- GAIN 497.3M
- IPO Year
- SIBN 2018
- GAIN 2005
- Fundamental
- Price
- SIBN $18.49
- GAIN $13.75
- Analyst Decision
- SIBN Strong Buy
- GAIN Hold
- Analyst Count
- SIBN 5
- GAIN 2
- Target Price
- SIBN $24.40
- GAIN $13.75
- AVG Volume (30 Days)
- SIBN 483.4K
- GAIN 111.9K
- Earning Date
- SIBN 05-05-2025
- GAIN 05-13-2025
- Dividend Yield
- SIBN N/A
- GAIN 10.93%
- EPS Growth
- SIBN N/A
- GAIN N/A
- EPS
- SIBN N/A
- GAIN 1.92
- Revenue
- SIBN $176,601,000.00
- GAIN $89,176,000.00
- Revenue This Year
- SIBN $18.52
- GAIN $6.75
- Revenue Next Year
- SIBN $16.39
- GAIN $12.51
- P/E Ratio
- SIBN N/A
- GAIN $7.18
- Revenue Growth
- SIBN 22.60
- GAIN 6.78
- 52 Week Low
- SIBN $11.70
- GAIN $11.42
- 52 Week High
- SIBN $19.16
- GAIN $14.85
- Technical
- Relative Strength Index (RSI)
- SIBN 78.21
- GAIN 52.98
- Support Level
- SIBN $13.64
- GAIN $13.67
- Resistance Level
- SIBN $18.91
- GAIN $13.98
- Average True Range (ATR)
- SIBN 0.77
- GAIN 0.27
- MACD
- SIBN 0.58
- GAIN -0.01
- Stochastic Oscillator
- SIBN 92.53
- GAIN 60.98
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to (i) achieve and grow current income by investing in debt securities of established businesses. (ii) provide our stockholders with long-term capital appreciation in the value of our assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.